John Parkinson

US government has purchased this batch of vaccines, which Moderna will manufacture concurrently with its phase 3 trials.

RLF-100 is an investigational therapy granted an FDA IND this week and looks to treat moderate and severe cases of COVID-19.

Investigational therapy, RLF-100, is being studied with the goal of preventing progression to respiratory failure.

This finding suggests large disparities in kids and echoes adult population positive rates.

The Novavax NVX-CoV2373 vaccine candidate is shown to be well-tolerated and elicited antibody response.

Two studies will investigate monoclonal antibody-based treatments in both patients with mild disease and those who are hospitalized.

An understanding of what one country saw earlier this year and the prospect of what other countries can do for future openings.

A New York City cardiologist talks about the presentation of patients with severe COVID-19 who experienced this condition.

After review of 2 randomized trials, a panel of health care providers and patients see limited benefit for the medication.

Medha Munshi, MD, discusses the specific challenges of the quarantine and how she was able to help her patients with diabetes comply with their care.

Manufacturers announce their supplies are being sent out for the upcoming season.

GSK, Sanofi were selected by US Operation Warp Speed to provide a large supply.

IDSA, HIVMA request they be included in ongoing COVID-19 clinical trials.

Roche’s tocilizumab did not improve clinical status in hospitalized adult patients with severe COVID-19 associated pneumonia.

One cardiologist speaks about what she witnessed in her NYC hospital including how the virus can be multi-organ and the development of COVID-19 diagnostic protocols.

The federal agency gives approval for technology company’s test that supports unmonitored testing.

The randomized, placebo-controlled trial will be enrolling 30000 American adults to test the safety and efficacy of the codeveloped vaccine.

Researchers have identified which olfactory cell types are vulnerable to the virus.

FDA reissues LabCorp’s existing diagnostic test for EUA, which opens up testing protocol for anyone.

The NIAID director offered nuanced advice on kids going back to school, getting to a baseline in the US, and how to prepare for the upcoming influenza season combined with COVID-19.

A small study reports no mother-to-newborn transmission of virus.

In this second installment of his interview, Howard Koh, MD, MPH, discusses the importance of providers and health care workers wearing face masks during their interactions with patients.

HHS is securing Pfizer and BioNTech’s BNT162 vaccine as soon as FDA approves.

A former Assistant Secretary of Health calls upon both to consider how a face mask mandate could mitigate transmission and mortality.

The FDA clears way for next phase for abivertinib to treat hospitalized patients.

This was seen in patients who were receiving either invasive mechanical ventilation or oxygen.

Luminex Receives FDA Emergency Use Authorization for its xMAP SARS-CoV-2 Multi-Antigen IgG Assay.

In a small Italian study, a majority of patients who were hospitalized and recovered from the virus, had lingering symptoms and many had a “worsened quality of life.”

A paper examines how these droplets are transmitted and ways to protect these providers from COVID-19.

Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.